The UK Medicines and Healthcare products Regulatory Agency (MHRA) is currently testing a new robotic system called the CellQualia Intelligent Cell Processing System, which has the potential to revolutionize the production of stem cell-based therapeutics. Stem cells are valuable in medicine because they can replace damaged or lost cells due to diseases.